BofA downgraded Reckitt Benckiser (RBGLY) to Neutral from Buy citing a lack of near-term catalysts and its preference for Unilever. Optimize ...

(RTTNews) - British nutrition products maker Reckitt Benckiser (RBGPF.PK, RB.L) reported Thursday lower profit in fiscal 2024, with slight decline in revenues. Further, the Board of Directors ...

Reckitt Benckiser’s profits fell short of analysts’ expectations last year, despite burgeoning hopes of a turnaround at the consumer goods giant. The owner of brands like Strepsils, Dettol and Lemsip, ...

Revenue: UK£14.2b (down 3.0% from FY 2023). Net income: UK£1.43b (down 13% from FY 2023). Profit margin: 10% (down from 11% in FY 2023). EPS: UK£2.04 (down from UK£2.28 in FY 2023). Revenue ...

Reckitt Benckiser’s RKT1.44%increase; green up pointing triangle shares rose after the company said adjusted profit beat market expectations, despite lower sales, as it continues to progress ...

Reckitt Benckiser is continuing to assess options for its nutrition operations housing the Mead Johnson infant-formula business. After describing nutrition as “non-core” in July as part of a ...

Reckitt Benckiser's shares rose after the company said adjusted profit beat market expectations, despite lower sales, as it continues to progress with its turnaround plans. Shares in morning trade ...

Reckitt Benckiser's adjusted profit beat market expectations, despite lower sales, as the company continues to progress with its turnaround plans. The consumer-goods company--which houses Dettol ...

Reckitt has shown a medium-term uptrend since April 2024, outperforming peers, but litigation risks from Mead Johnson remain substantial, making the stock a hold. Reckitt's strategic focus on high ...

Reckitt Benckiser’s share price is down 2% in early trading this morning after its results fell short of analysts’ expectations. The owner of brands like Strepsils, Dettol, and Lemsip, saw operating ...

LONDON (Reuters) -Britain's Reckitt Benckiser, the maker of Strepsils throat lozenges and Dettol cleaning products, missed expectations for fourth-quarter like-for-like net sales as a late flu and ...